A detailed history of National Pension Service transactions in Amgen Inc stock. As of the latest transaction made, National Pension Service holds 1,064,291 shares of AMGN stock, worth $306 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
1,064,291
Previous 926,058 14.93%
Holding current value
$306 Million
Previous $289 Million 18.52%
% of portfolio
0.34%
Previous 0.33%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$309.38 - $337.38 $42.8 Million - $46.6 Million
138,233 Added 14.93%
1,064,291 $343 Million
Q2 2024

Aug 12, 2024

BUY
$262.75 - $319.31 $5.34 Million - $6.49 Million
20,321 Added 2.24%
926,058 $289 Million
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $2.34 Million - $2.82 Million
8,702 Added 0.97%
905,737 $258 Million
Q4 2023

Feb 06, 2024

BUY
$255.7 - $288.46 $4.56 Million - $5.14 Million
17,831 Added 2.03%
897,035 $258 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $2.4 Million - $2.99 Million
10,997 Added 1.27%
879,204 $236 Million
Q2 2023

Aug 15, 2023

BUY
$214.27 - $253.37 $10.2 Million - $12 Million
47,397 Added 5.77%
868,207 $193 Million
Q1 2023

May 11, 2023

SELL
$225.79 - $275.2 $733,140 - $893,574
-3,247 Reduced 0.39%
820,810 $198 Million
Q4 2022

Feb 23, 2023

SELL
$229.03 - $291.01 $1.38 Million - $1.76 Million
-6,037 Reduced 0.73%
824,057 $216 Million
Q4 2022

Feb 17, 2023

SELL
$229.03 - $291.01 $1.38 Million - $1.76 Million
-6,037 Reduced 0.73%
824,057 $216 Million
Q3 2022

Feb 23, 2023

BUY
$224.46 - $253.15 $1.36 Million - $1.53 Million
6,037 Added 0.73%
830,094 $187 Million
Q3 2022

Nov 17, 2022

BUY
$224.46 - $253.15 $2.44 Million - $2.75 Million
10,854 Added 1.32%
830,094 $190 Million
Q2 2022

Aug 17, 2022

BUY
$230.71 - $256.74 $14.1 Million - $15.7 Million
61,187 Added 8.07%
819,240 $199 Million
Q1 2022

May 13, 2022

BUY
$219.27 - $242.57 $1.4 Million - $1.55 Million
6,378 Added 0.85%
758,053 $183 Million
Q4 2021

Feb 15, 2022

SELL
$198.88 - $227.6 $930,957 - $1.07 Million
-4,681 Reduced 0.62%
751,675 $169 Million
Q3 2021

Nov 18, 2021

BUY
$212.27 - $248.7 $426,874 - $500,135
2,011 Added 0.27%
756,356 $161 Million
Q2 2021

Aug 17, 2021

BUY
$233.58 - $259.14 $2.48 Million - $2.75 Million
10,624 Added 1.43%
754,345 $184 Million
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $2.15 Million - $2.5 Million
9,680 Added 1.32%
743,721 $185 Million
Q4 2020

Feb 19, 2021

BUY
$216.38 - $257.67 $4.16 Million - $4.95 Million
19,227 Added 2.69%
734,041 $169 Million
Q2 2020

Aug 11, 2020

SELL
$197.81 - $242.74 $224,316 - $275,267
-1,134 Reduced 0.16%
714,814 $169 Million
Q1 2020

May 27, 2020

BUY
$182.24 - $241.7 $1.57 Million - $2.08 Million
8,602 Added 1.22%
715,948 $145 Million
Q4 2019

Feb 21, 2020

SELL
$189.21 - $243.2 $707,834 - $909,811
-3,741 Reduced 0.53%
707,346 $171 Million
Q3 2019

Nov 15, 2019

BUY
$174.11 - $208.62 $5.9 Million - $7.07 Million
33,874 Added 5.0%
711,087 $138 Million
Q2 2019

Aug 14, 2019

BUY
$166.7 - $195.41 $3.28 Million - $3.84 Million
19,651 Added 2.99%
677,213 $125 Million
Q1 2019

May 15, 2019

BUY
$180.87 - $203.88 $4.31 Million - $4.86 Million
23,824 Added 3.76%
657,562 $125 Million
Q4 2018

Feb 15, 2019

BUY
$178.4 - $208.25 $6.66 Million - $7.77 Million
37,316 Added 6.26%
633,738 $118 Million
Q3 2018

Nov 15, 2018

BUY
$185.29 - $208.89 $553,646 - $624,163
2,988 Added 0.5%
596,422 $124 Million
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $6.82 Million - $7.66 Million
41,056 Added 7.43%
593,434 $109 Million
Q1 2018

Apr 13, 2018

SELL
$169.43 - $198.0 $5.31 Million - $6.21 Million
-31,356 Reduced 5.37%
552,378 $94.2 Million
Q4 2017

Jan 17, 2018

BUY
$168.79 - $188.59 $2.51 Million - $2.81 Million
14,898 Added 2.62%
583,734 $102 Million
Q3 2017

Oct 16, 2017

BUY
$167.29 - $191.0 $95.2 Million - $109 Million
568,836
568,836 $105 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track National Pension Service Portfolio

Follow National Pension Service and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Pension Service, based on Form 13F filings with the SEC.

News

Stay updated on National Pension Service with notifications on news.